Physician profile
Erin Tuttle
NPI 1740700525
$1,472.71
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $789 · 2020: $95.39 · 2021: $13.86 · 2022: $210 · 2023: $308 · 2024: $56.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $364.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $428.05 | 2019 | |
| Genzyme Corporation | $299.29 | 2022-2024 | |
| Pfizer INC. | $143.91 | 2019-2022 | |
| Insmed, INC. | $124.99 | 2023 | Arikayce |
| Abbvie INC. | $123.81 | 2019 | |
| Amarin Pharma, INC. | $105.00 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $95.39 | 2020 | |
| Csl Behring | $58.06 | 2022-2023 | Kcentra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.33 | 2024 | Ofev |
| Merck Sharp & Dohme LLC | $19.08 | 2022 | |
| Mylan Specialty L.P. | $18.08 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $16.02 | 2023 | Fasenra |
| Atricure, INC. | $12.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Tuttle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.